Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

879
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
879

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.

Frontiers in oncology·2026
Same author

Frequency of Bacteremia and the Preventive Effect of Prophylactic Antibiotics in Direct Peroral Cholangioscopy During Endoscopic Retrograde Cholangiopancreatography: A Real-life Retrospective Analysis.

The Israel Medical Association journal : IMAJ·2026
Same author

Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.

Endocrine-related cancer·2026
Same author

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.

Cell reports·2026
Same author

A new, machine learning-based approach to metastatic neuroendocrine tumors of unknown origin.

Journal of neuroendocrinology·2026
Same author

Universal submucosal dissection outperforms selective mucosal resection in early esophageal adenocarcinoma.

Endoscopy·2026

Related Experiment Video

Updated: Sep 8, 2025

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
05:42

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Published on: January 3, 2020

8.3K

[Endoscopic Resection for GEP-NET].

Hanno Ehlken1, Fadi Younis1, Stefan Wolter2

  • 1Klinik und Poliklinik für interdisziplinäre Endoskopie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.

Zentralblatt Fur Chirurgie
|June 15, 2022
PubMed
Summary

Endoscopic resection is suitable for small gastrointestinal neuroendocrine tumors (NET) less than 1 cm. Larger NETs or those in the jejunum/ileum require surgical intervention due to metastasis risk.

More Related Videos

Application of End-to-end Anastomosis in Robotic Central Pancreatectomy
10:58

Application of End-to-end Anastomosis in Robotic Central Pancreatectomy

Published on: June 2, 2018

8.1K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.1K

Related Experiment Videos

Last Updated: Sep 8, 2025

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
05:42

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Published on: January 3, 2020

8.3K
Application of End-to-end Anastomosis in Robotic Central Pancreatectomy
10:58

Application of End-to-end Anastomosis in Robotic Central Pancreatectomy

Published on: June 2, 2018

8.1K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.1K

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Endocrinology

Background:

  • Neuroendocrine tumors (NET) are rare gastrointestinal malignancies.
  • Many NETs are incidentally discovered during endoscopy.
  • Complete surgical resection is the primary treatment for localized NETs.

Purpose of the Study:

  • To define the criteria for endoscopic versus surgical resection of gastrointestinal NETs.
  • To evaluate the feasibility and outcomes of endoscopic resection for specific NET locations and sizes.
  • To explore novel approaches for managing intermediate-sized NETs.

Main Methods:

  • Review of current treatment guidelines and literature on gastrointestinal NETs.
  • Analysis of tumor size, location, and metastatic potential in relation to resection modality.
  • Evaluation of endoscopic resection feasibility based on R0 resection rates, complications, and lymph node metastasis risk.

Main Results:

  • Endoscopic resection is standard for gastric, duodenal, and rectal NETs < 1 cm without metastasis risk factors.
  • Jejunal and ileal NETs should not be treated endoscopically due to high metastasis rates.
  • Tumors > 2 cm generally require surgical resection; those 1-2 cm may be managed surgically or endoscopically, with combined approaches considered.

Conclusions:

  • Treatment decisions for gastrointestinal NETs should be guided by tumor size, location, and metastatic risk.
  • Endoscopic resection is a safe and effective option for select small NETs.
  • Novel combined endoscopic-laparoscopic techniques offer a promising organ-sparing approach for intermediate-sized NETs.